- Home
- TARS vs PRKS Comparison
TARS vs PRKS Comparison
Compare TARS & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | PRKS |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TARS | PRKS |
|---|---|---|
| Price | $81.84 | $36.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $76.56 | $50.82 |
| AVG Volume (30 Days) | 514.1K | ★ 800.0K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.27 |
| Revenue | $366,100,000.00 | ★ $1,673,396,000.00 |
| Revenue This Year | $147.24 | N/A |
| Revenue Next Year | $53.11 | $2.24 |
| P/E Ratio | ★ N/A | $11.02 |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | $29.62 |
| 52 Week High | $85.25 | $60.63 |
Technical Indicators
Market Signals| Indicator | TARS | PRKS |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 48.14 |
| Support Level | $77.14 | $34.21 |
| Resistance Level | $84.07 | $35.48 |
| Average True Range (ATR) | 2.91 | 1.11 |
| MACD | -0.19 | 0.35 |
| Stochastic Oscillator | 58.84 | 52.88 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.